Reaction
Fungal Endocarditis reporting signals
As of the last recalculation, Fungal Endocarditis appears in 290 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is AMPHOTERICIN B (PRR 313.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Amphotericin B | 46 | 313.0 | 314.2 |
| Voriconazole Injection | 52 | 209.2 | 209.7 |
| Micafungin Sodium | 20 | 181.8 | 182.2 |
| Voriconazole | 56 | 163.7 | 164.0 |
| Itraconazole | 23 | 153.4 | 153.7 |
| Valganciclovir Hydrochloride Powder, | 13 | 80.0 | 80.1 |
| Valganciclovir | 16 | 64.4 | 64.5 |
| Valganciclovir Hydrochloride | 16 | 64.4 | 64.5 |
| Gentamicin Sulfate | 12 | 56.8 | 56.9 |
| Gentamicin | 10 | 56.8 | 56.8 |
| Meropenem | 23 | 55.8 | 55.8 |
| Posaconazole Delayed-Release | 8 | 53.7 | 53.8 |
| Nebivolol | 11 | 51.5 | 51.5 |
| Vancomycin | 35 | 49.3 | 49.3 |
| Deferasirox | 11 | 30.9 | 30.9 |
| Remdesivir | 4 | 21.8 | 21.8 |